Overview

Efficacy and Safety of Levocetirizine for Treatment of Recurrent Cough Associated With Other Allergic Symptoms in Children

Status:
Completed
Trial end date:
2003-03-01
Target enrollment:
0
Participant gender:
All
Summary
Efficacy and Safety of Levocetirizine for Treatment of Recurrent Cough Associated With Other Allergic Symptoms in Children
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
UCB Pharma
Treatments:
Cetirizine
Levocetirizine
Criteria
Inclusion Criteria:

- infants from 2 to 24 months both inclusive

- suffering from recurrent cough associated with other allergic symptoms

- hospitalized for respiratory or allergy related problems

- laboratory results within normal ranges

- height and weight between percentile 5 and 95

Exclusion Criteria:

- having taken any of the disallowed medication

- suffering form any disorder

- history of sleep apnea

- having concomitant chronic disease

- known relevant renal, hepatic, cardiac or metabolism dysfunction

- known alcohol or drug addiction, severe psychiatric disease for the parent/guardian